Ursal, Jayver .
HRN: 24-70-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/22/2024
CEFTRIAXONE 1G (VIAL)
03/22/2024
03/28/2024
IV DRIP
1gm
Q12
Orchitis, T/C Complicated UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes